BRIGATINIB

brigatinib 180 mg tablet, 28

BRIGATINIB (11984R)

brigatinib 180 mg tablet, 28
11984R
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Stage IIIB (locally advanced) or Stage IV (metastatic) non-small cell lung cancer (NSCLC)
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 28 # of repeats: 3 DPMQ: $6,483.36 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Alunbrig